1. Beattie CW, Hansen NW, Thomas PA (1985) Steroid receptors in human lung cancer. Cancer Res 45: 4206–4214
2. Dammann CE, Ramadurai SM, McCants DD, Pham LD, Nielsen HC (2000) Androgen regulation of signaling pathways in late fetal mouse lung development. Endocrinology 141: 2923–2929
3. Di Lorenzo G, Tortora G, D’Armiento FP, De Rosa G, Staibano S, Autorino R, D’Armiento M, De Laurentiis M, De Placido S, Catalano G, Bianco AR, Ciardiello F (2002) Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin Cancer Res 8: 3438–3444
4. Fandi A, Gatzemeier U, Smith R, Averbuch S, Manegold C (2003) Final data from a pilot trial of gefitinib (ZD1839) in combination with docetaxel in patients with advanced or metastatic non-small-cell lung cancer (NSCLC): Safety and pharmacokinetics. Proc Am Soc Clin Oncol 22: 655
5. Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0 (IARC, CancerBase No. 5). Lyon, France: IARC Press